Scio Township recently approved two conditional uses that should bring some new helpful services to the community. One was ..

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

KENLY – Johnston County deputy converged on the campus of Glendale Elementary School on Bay Valley Road near Kenly for a ...

Talking on cell phones while walking down the streets of Bhopal appears to be no more safe as mobile phone snatchers have ...

Researchers in China have developed the next-generation solar cell, known as the perovskite-organic solar cell.

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

November 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a cancer-free future by using its INTASYL ® siRNA gene silencing ...

BLUETTI, a leader in portable power stations and eco-friendly energy solutions, launches the Elite 200 V2, a 2KWh ...

On the campaign trail, incoming US president Donald Trump vowed to release Silk Road creator Ross Ulbricht from prison if ...

FREYR Battery shifts toward sustainability with solar assets acquisition. Find out why FREY stock may face challenges amid ...